Athersys, Inc. focuses on the research and development activities in the field of regenerative medicine.Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead product includes MultiStem cell therapy, an allogeneic stem cell product, which is in Phase III clinical study.
